US 10,376,498 B2
3-alkyl pyridinium compound from red sea sponge with potent antiviral activity
Christian R. Voolstra, Thuwal (SA); Aubrie O'Rourke, Thuwal (SA); and Stephan Kremb, Thuwal (SA)
Assigned to King Abdullah University of Science and Technology, Thuwal (SA)
Appl. No. 15/520,811
Filed by KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY, Thuwal (SA)
PCT Filed Oct. 29, 2015, PCT No. PCT/IB2015/002187
§ 371(c)(1), (2) Date Apr. 20, 2017,
PCT Pub. No. WO2016/067099, PCT Pub. Date May 6, 2016.
Claims priority of provisional application 62/072,292, filed on Oct. 29, 2014.
Prior Publication US 2018/0000799 A1, Jan. 4, 2018
Int. Cl. A61K 31/439 (2006.01); A61K 31/4375 (2006.01); A61K 35/655 (2015.01)
CPC A61K 31/439 (2013.01) [A61K 31/4375 (2013.01); A61K 35/655 (2015.01); Y02A 50/385 (2018.01); Y02A 50/387 (2018.01); Y02A 50/393 (2018.01)] 8 Claims
OG exemplary drawing
 
1. A method for treating a viral infection in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound, or a pharmaceutically acceptable salt thereof, wherein the compound comprises at least one alkyl pyridinium compound represented by Formula (3):

OG Complex Work Unit Drawing
wherein x and y, independently of each other, are each 5-15.